Medicover and Synevo’s total revenues in Romania up 27 pct in 2018

Anca Alexe 15/02/2019 | 15:28

Medicover, an international healthcare and diagnostics services company listed on the Stockholm Stock Exchange presented its preliminary financial results for 2018. Over the year, Medicover had a global revenue growth of 15.8 percent compared to 2017, up to EUR 671.6 million.

Medicover is active in Romania through its Medicover medical clinics and its Synevo labs.

The company’s total revenues on the Romanian market increased in 2018 by 27.1 percent, up to EUR 93.8 million. Romania is the third market by share of the global revenue levels, after Germany and Poland, with a 13.9 percent share.

“We ended 2018 with a stronger network and a wider national coverage. The acquisitions we made throughout the year both in Bucharest as well as in Oradea and the Oltenia region consolidated our market position and brought us closer to patients. We will continue to develop in 2019 and offer the highest quality of services and investments in digitalization and patient experience,” said Adrian Peake, the general director of Medicover Romania.

Medicover’s clinic network in Romania increased by 50 percent in 2018 to reach 37 units as a result of transactions including the acquisition of the Pelican Hospital in Oradea, the two clinics owned by the Academica Medical Centre in Bucharest and the Phoenix Medical Centre, a private medical operator in Oltenia that owns an eight-clinic network in various cities in the region.

The Synevo network in Romania had a total of 99 collection centres in 33 counties and 42 cities in the country.

BR Magazine | Latest Issue

Download PDF: Business Review Magazine April 2024 Issue

The April 2024 issue of Business Review Magazine is now available in digital format, featuring the main cover story titled “Caring for People and for the Planet”. To download the magazine in
Anca Alexe | 12/04/2024 | 17:28
Advertisement Advertisement
Close ×

We use cookies for keeping our website reliable and secure, personalising content and ads, providing social media features and to analyse how our website is used.

Accept & continue